Effect of introducing human papillomavirus genotyping into real-world screening on cervical cancer screening in China: a retrospective population-based cohort study
Background: China’s Fujian Cervical Pilot Project (FCPP) transitioned cervical cancer screening from high-risk human papillomavirus (HR-HPV) nongenotyping to genotyping. We investigated the clinical impact of this introduction, comparing performance indicators between HR-HPV genotyping combined with...
Main Authors: | Binhua Dong, Huachun Zou, Xiaodan Mao, Yingying Su, Hangjing Gao, Fang Xie, Yuchun Lv, Yaojia Chen, Yafang Kang, Huifeng Xue, Diling Pan, Pengming Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-04-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/17588359211010939 |
Similar Items
-
Cost-effectiveness and accuracy of cervical cancer screening with a high-risk HPV genotyping assay vs a nongenotyping assay in China: an observational cohort study
by: Binhua Dong, et al.
Published: (2020-08-01) -
The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China
by: Wang Shizhuo, et al.
Published: (2012-05-01) -
Coinfection of High-Risk Human Papillomavirus and Lower Genital Tract Pathogens in the Development of High-Grade Cervical Lesions
by: Hui Zhong, et al.
Published: (2020-01-01) -
Cervical Human Papillomavirus Screening among Older Women
by: Matthew J. Grainge, et al.
Published: (2005-11-01) -
Correlates of women’s intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval
by: Gina S. Ogilvie, et al.
Published: (2016-03-01)